BASELLI, GUIDO ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 1.964
NA - Nord America 1.484
AS - Asia 1.362
SA - Sud America 80
AF - Africa 30
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.940
Nazione #
US - Stati Uniti d'America 1.400
CN - Cina 612
IT - Italia 477
DE - Germania 448
GB - Regno Unito 373
SG - Singapore 241
SE - Svezia 170
RU - Federazione Russa 110
IN - India 101
IE - Irlanda 85
BR - Brasile 68
HK - Hong Kong 63
CA - Canada 62
FI - Finlandia 54
TR - Turchia 54
DK - Danimarca 52
FR - Francia 50
ID - Indonesia 50
JP - Giappone 45
VN - Vietnam 41
TW - Taiwan 37
KR - Corea 32
NL - Olanda 31
CH - Svizzera 21
BE - Belgio 18
IR - Iran 18
AU - Australia 17
MX - Messico 14
RO - Romania 13
AT - Austria 12
EG - Egitto 8
PK - Pakistan 8
PL - Polonia 8
UA - Ucraina 8
BD - Bangladesh 7
MY - Malesia 7
NO - Norvegia 7
PR - Porto Rico 6
TH - Thailandia 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
LK - Sri Lanka 5
SA - Arabia Saudita 5
TN - Tunisia 5
ES - Italia 4
GR - Grecia 4
NP - Nepal 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
HU - Ungheria 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
SC - Seychelles 3
UZ - Uzbekistan 3
BT - Bhutan 2
CM - Camerun 2
EC - Ecuador 2
NG - Nigeria 2
PT - Portogallo 2
PY - Paraguay 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 4.940
Città #
Southend 310
Hanover 207
Milan 179
Singapore 175
Fairfield 122
Frankfurt am Main 112
Chandler 103
Ashburn 78
Wilmington 77
Dublin 76
Beijing 72
Houston 62
Ann Arbor 59
Princeton 56
Council Bluffs 55
Woodbridge 49
Jakarta 48
Nanjing 46
Seattle 46
Shanghai 46
Berlin 42
Cambridge 42
Helsinki 37
Redwood City 37
Toronto 36
Istanbul 33
Santa Clara 30
Guangzhou 27
Dearborn 26
New York 22
Hong Kong 21
Bengaluru 20
Chengdu 19
Phoenix 19
Dong Ket 18
Falls Church 18
Hangzhou 18
Taipei 17
Changsha 16
Des Moines 16
Central District 15
Solna 15
Tokyo 15
Wuhan 15
Jinan 14
Nuremberg 14
Shenyang 14
São Paulo 14
Boardman 12
Los Angeles 12
Seoul 12
Tianjin 12
Brussels 11
Piscataway 11
Boston 10
Lucknow 10
Silver Spring 10
Zurich 10
Bari 9
Central 9
Chicago 9
London 9
Fuzhou 8
San Diego 8
Zhengzhou 8
Carlsbad 7
Edinburgh 7
Grafing 7
Padova 7
Taichung 7
Turin 7
Brisbane 6
Fremont 6
Hebei 6
Kent 6
Munich 6
Norwalk 6
Redmond 6
Rome 6
San Juan 6
Stockholm 6
Alessandria 5
Ankara 5
Cagliari 5
Denver 5
Genoa 5
Lappeenranta 5
Oxford 5
Rho 5
Roxbury 5
San Jose 5
Shenzhen 5
Taranto 5
Upper Marlboro 5
Viagrande 5
Vienna 5
Atlanta 4
Bethesda 4
Branson 4
Chongqing 4
Totale 2.971
Nome #
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 438
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 390
Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma 321
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 247
Beyond fat accumulation, NAFLD genetics converges on lipid droplet biology 230
FUNCTIONAL CHARACTERIZATION OF A NOVEL GENETIC VARIANT PREDISPOSING TO ADVANCED FIBROSIS AND HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NONALCOHOLIC FATTY LIVER DISEASE 209
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 196
Combined effects of nutrients and gut microbiota in the immunomodulation of DMD 191
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 183
Genetic insight into Covid-19 related liver injury 182
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 181
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 174
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 170
Emergency Lung Transplantation after {COVID}-19: Immunopathological Insights on Two Affected Patients 166
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 137
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 130
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice 121
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 117
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease 111
SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan 110
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 104
Impact of natural neuromedin-B receptor variants on iron metabolism 100
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis 100
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 97
Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradient 85
Association of ABO blood group and secretor phenotype with severe COVID-19 82
Reply to: "Lack of hepatic autophagy promotes severity of liver injury but not steatosis": ATG7 genetic variants behave as fatty liver disease progression modifiers 70
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 67
PSD3 downregulation confers protection against fatty liver disease 65
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 64
Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis 58
Genetics of nonalcoholic fatty liver disease : a 2018 update 46
Whole exome sequencing for personalized hepatology : expanding applications in adults and challenges 46
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease 43
3D cephalometric normality range : Auto Contractive Maps (ACM) analysis in selected Caucasian skeletal class I age groups 42
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort 35
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b 33
Totale 5.141
Categoria #
all - tutte 17.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 0 0 0 62 45 41
2020/2021712 34 54 21 45 66 71 46 44 77 102 56 96
2021/20221.157 65 75 117 72 103 111 96 110 148 95 69 96
2022/2023777 86 62 66 60 74 126 49 40 88 17 74 35
2023/2024807 33 69 40 87 163 50 68 51 41 40 70 95
2024/2025918 64 150 54 125 105 84 114 149 72 1 0 0
Totale 5.141